We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HWELW
1226
CALL
DELISTED
Healthwell Acquisition Corp. I Warrant
HWELW
$4.55M 0.01%
458,844
SYNA icon
1227
Synaptics
SYNA
$4.55B
$4.54M 0.01%
47,737
+5,312
+13% +$511K
PORT.WS
1228
CALL
DELISTED
Southport Acquisition Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50
PORT.WS
$4.54M 0.01%
445,667
INTE
1229
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
$4.53M 0.01%
448,247
CNK icon
1230
Cinemark Holdings
CNK
$3.93B
$4.53M 0.01%
522,980
+260,710
+99% +$2.94M
PUCKW
1231
CALL
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$4.53M 0.01%
450,000
WELL icon
1232
Welltower
WELL
$175B
$4.53M 0.01%
69,045
-230,935
-77% -$14.8M
STRO icon
1233
Sutro Biopharma
STRO
$398M
$4.52M 0.01%
55,992
+3,630
+7% +$252K
KNBE
1234
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
$4.52M 0.01%
182,500
+165,419
+968% +$4.03M
COUP
1235
DELISTED
Coupa Software Incorporated
COUP
$4.52M 0.01%
+57,115
New +$3.42M
XLY icon
1236
CALL
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.6B
$4.51M 0.01%
69,800
-47,200
-40% -$3.29M
HGV icon
1237
Hilton Grand Vacations
HGV
$3.98B
$4.5M 0.01%
116,831
+108,731
+1,342% +$4.3M
CBT icon
1238
Cabot Corp
CBT
$4.61B
$4.5M 0.01%
67,352
-329,467
-83% -$23M
AEACW
1239
CALL
DELISTED
Authentic Equity Acquisition Corp. Warrant
AEACW
$4.49M 0.01%
444,211
DLCAW
1240
CALL
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$4.49M 0.01%
445,024
JACK icon
1241
Jack in the Box
JACK
$299M
$4.49M 0.01%
65,806
-21,638
-25% -$1.66M
MPC icon
1242
PUT
Marathon Petroleum
MPC
$91.2B
$4.48M 0.01%
38,500
+3,100
+9% +$353K
LGVC
1243
DELISTED
LAMF Global Ventures Corp. I Class A Ordinary Shares
LGVC
$4.47M 0.01%
435,901
OMF icon
1244
CALL
OneMain Financial
OMF
$7.08B
$4.45M 0.01%
+133,700
New +$4.74M
AISP
1245
Airship AI Holdings
AISP
$67.8M
$4.44M 0.01%
440,199
-864,217
-66% -$8.65M
SHG icon
1246
Shinhan Financial Group
SHG
$33.6B
$4.43M 0.01%
158,755
-94,427
-37% -$2.54M
GTACW
1247
CALL
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$4.42M 0.01%
429,791
TEL icon
1248
TE Connectivity
TEL
$60.2B
$4.42M 0.01%
38,486
-97,558
-72% -$11.6M
RCFA
1249
DELISTED
Perception Capital Corp. IV
RCFA
$4.41M 0.01%
430,055
PHYT.WS
1250
CALL
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$4.39M 0.01%
425,200

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.